June 7th, Beijing, China

The 2014 BIO International Convention will be held on June 23rd-26th in San Diego, USA. Dr. Jun Bao, Senior Vice President & Chief Business Officer of Shenogen Pharma Group, will attend the event. BIO is the largest veue for private company-to-company meetings in the world. On behalf of Shenogen, Dr. Bao aims to look for global partners via BIO’s one-on-one partnering system.

About Shenogen

Shenogen Pharma Group is a drug discovery and development company based in Beijing, China, that dedicated the development of first-in-class therapeutics for cancer treatment. We possess robust intellectual property rights around a novel membrane-bound estrogen receptor, ER-alpha 36, which is related to tumor metastasis. Under the motto of “Better Medicine, Better Life” and a seasoned management team, together with our partners, Shenogen has developed an impressive product pipeline. Our pipeline consists of novel small molecule and antibody therapeutics for cancer treatment which includes liver cancer, breast cancer, other solid tumors and leukemia. Our lead molecule, icaritin, is currently in Ph II clinical trial for treatment of advanced hepatocellular carcinoma.